MarketResearchReport2021

  Erectile Dysfunction Drugs Market 2021 According to Market Research Future (MRFR), the global  erectile dysfunction drugs market  is expected to reach a market value of  USD 2930 million  with a  CAGR of 3.5% from 2019 to 2025  (forecast period). The report introspects the opportunities, challenges, cost structure, and recent developments pertaining to the erectile dysfunction drugs market in the report and the impact of the COVID-19 on these facets. Erectile dysfunction is also referred to as impotence and is characterized by an inability to build up or maintain a penile erection during sexual intercourse. Penis erection involves a hydraulic effect resulting from the entry and retention of blood into spongy bodies within the penis. Sexual arousal is responsible for the initiation of this process, indicated by the brain-to-penile nerve impulse mechanism. The causes of erectile dysfunction include adverse effects of medications, cavernosal disorders, neurogenic disorders, aging, psych

  Erectile Dysfunction Drugs Market 2021 Erectile dysfunction is the inability to attain or maintain penile erection in men, sufficient for successful sexual intercourse. It is also known as impotence. It is a common medical disorder primarily affecting men older than 40 years of age. Growing elderly population, increasing awareness and patient education, elevated inclination towards a sedentary lifestyle, and growing incidence of several genitourinary diseases are some of the factors expected to drive the growth of the global erectile dysfunction drugs market. Management of this disorder includes medical history, sexual history and psychological history of a person. There are number of drugs available for the treatment of erectile dysfunction which include both branded and generic drugs. Over 20 million men all over the world have used or are currently using Viagra to treat erectile dysfunction. Stress and mental health concerns may worsen the problem of erectile dysfunction. Physical